- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Advanced Parkinson Disease
- Meeting Date: May 2024
- Public Summary Document (PSD) May 2024 PBAC Meeting - (PDF 758KB)
- Public Summary Document (PSD) May 2024 PBAC Meeting - (Word 146KB)
Foslevodopa with foscarbidopa – May 2024
Foslevodopa with foscarbidopa: Solution for subcutaneous infusion foslevodopa 2400 mg with foscarbidopa 120 mg in 10 mL; Vyalev®
Last updated
30 May 2025